Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation

This publication has 16 references indexed in Scilit:

• Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes
  Stroke, 2001
• Antithrombotic Therapy in Atrial Fibrillation
  Chest, 2001
• Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation
  Stroke, 1999
• Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III Study
  JAMA, 1998
• The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous Thrombosis
  Annals of Internal Medicine, 1998
• Prevalence of 20210 A Allele of the Prothrombin Gene in Venous Thromboembolism Patients
  Thrombosis and Haemostasis, 1998
• The Prothrombin 20210A Allele Is the Most Prevalent Genetic Risk Factor for Venous Thromboembolism in the Spanish Population
  Thrombosis and Haemostasis, 1998
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Resistance to Activated Protein C as a Basis for Venous Thrombosis
  New England Journal of Medicine, 1994
• Clinical uses of two dimensional echocardiography
  The American Journal of Cardiology, 1980